Results 51 to 60 of about 134,783 (203)

Circulating exosomes secreted by osteosarcoma cells are potential biomarkers for metastasis

open access: yes, 2021
Selva, Erica M.Sampson, ValerieOsteosarcoma is a primary malignant bone tumor found in children and is the third most common cancer in children and adolescents.
Jeshurin, Madeline
core   +1 more source

Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control study

open access: yesCanine Medicine and Genetics, 2021
Background Osteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have reported epidemiological associations suggesting that large body mass, long bone length and the genetics of certain breeds including the Rottweiler are ...
Grace L. Edmunds   +7 more
doaj   +1 more source

In vitro studies on MG63 osteosarcoma cells: mitochondrial phenotype differences in doxorubicin resistance

open access: yes, 2022
reservedLa doxorubicina è un farmaco chemioterapico impiegato per il trattamento di diversi tumori solidi tra cui l’osteosarcoma. Nonostante la comprovata efficacia clinica di questo farmaco, il suo utilizzo rimane problematico sia per la severita ...
GANARIN, ALEXIA
core  

Osteosarcoma periosteal en perro - Informe de caso [PDF]

open access: yes, 2018
Osteosarcoma is the most common bone tumor in dogs. The periosteal osteosarcoma is a subtype of osteosarcoma, and is considered rare in the canine species.
Hough Monteiro, Julio Edward   +4 more
core   +3 more sources

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

open access: yes, 2022
Background: Despite (neo)adjuvant chemotherapy with cisplatin, doxorubicin and methotrexate, some patients with primary osteosarcoma progress during first-line systemic treatment and have a poor prognosis.
Hagleitner, dr. M.M. (Radboud University) DAI=info:eu-repo/dai/nl/321543564   +29 more
core   +1 more source

Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: The cellular and molecular mechanisms of tumour response following chemotherapy are largely unknown. We found that low dose anti-tumour agents up-regulate early growth response 1 (EGR1) expression. EGR1 is a member of the immediate-early gene
Yukihiro Matsunoshita   +7 more
doaj   +1 more source

Osteosarcoma costal [PDF]

open access: yes, 2011
I El Prof. Luque presenta la historia clínica, con dos ilustraciones, de un joven con un tumor localizado en la región intervértebro-escapular derecha.
Luque, Manuel José
core  

Osteosarcoma of the maxilla

open access: yesJournal of the Belgian Society of Radiology, 2012
Background: A 25-year-old male patient presented with tooth pain and progressive swelling of his left cheek. Dental examination was unremarkable.
Vanhoenacker, F.M.   +3 more
openaire   +7 more sources

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

open access: yes, 2023
Hongliang Wu,1– 3 Sihang Zheng,4 Qun He,5 Yan Li3 1Department of Orthopedics, Fuzhou Second Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China; 2Department of Orthopedics, Fuzhou Second Hospital ...
Li Y, Zheng S, He Q, Wu H
core  

Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro

open access: yesTumor Biology, 2017
We aimed to study the anti-tumor effects of triptolide on osteosarcoma and the related molecular mechanisms. The cell viability, apoptosis portion, tumor size, tumor weight, and invasion of osteosarcoma cells were determined.
Chunming Jiang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy